Augusto Giannini
Overview
Explore the profile of Augusto Giannini including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
365
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Femia A, Soares P, Luceri C, Lodovici M, Giannini A, Caderni G
BMC Cancer
. 2015 Sep;
15:611.
PMID: 26335331
Background: Recently, we showed that Sulindac (SU; 320 ppm) reduces precancerous lesions in the colon of Pirc rats, mutated in the Apc gene. Surprisingly, previous data in Apc-mutated mice showed...
2.
Galardi F, Oakman C, Truglia M, Cappadona S, Biggeri A, Grisotto L, et al.
Breast
. 2012 Mar;
21(3):336-42.
PMID: 22406214
There are no clinical tools to functionally assess degree of DNA damage in breast cancer. The comet assay is an accepted research tool for assessing DNA damage, however, most cancer...
3.
Femia A, Luceri C, Toti S, Giannini A, Dolara P, Caderni G
BMC Cancer
. 2010 May;
10:194.
PMID: 20459814
Background: Azoxymethane (AOM) or 1,2-dimethylhydrazine (DMH)-induced colon carcinogenesis in rats shares many phenotypical similarities with human sporadic colon cancer and is a reliable model for identifying chemopreventive agents. Genetic mutations...
4.
Pestrin M, Bessi S, Galardi F, Truglia M, Biggeri A, Biagioni C, et al.
Breast Cancer Res Treat
. 2009 Jul;
118(3):523-30.
PMID: 19597704
Biocharacterization of circulating tumor cells (CTCs) in the peripheral blood of advanced breast cancer (ABC) patients may represent a real-time tumor biopsy. We assessed HER2 status on CTCs from blood...
5.
Femia A, Giannini A, Fazi M, Tarquini E, Salvadori M, Roncucci L, et al.
Cancer Prev Res (Phila)
. 2009 Jan;
1(7):562-7.
PMID: 19139006
Aberrant crypt foci (ACF) originally described in rodents treated with colon-specific carcinogens have been identified also in humans at high risk of colon cancer (CRC) and are extensively used as...
6.
Femia A, Dolara P, Servili M, Esposto S, Taticchi A, Urbani S, et al.
Eur J Nutr
. 2008 Aug;
47(6):329-34.
PMID: 18677543
Background: Some epidemiological and experimental studies suggest that olive oil, despite its elevated caloric content, may have protective activity against colon cancer, partially due to its phenolic content. However, little...
7.
Femia A, Tarquini E, Salvadori M, Ferri S, Giannini A, Dolara P, et al.
Int J Cancer
. 2007 Sep;
122(1):117-23.
PMID: 17847023
K-ras and mucin profile variations, associated with intestinal carcinogenesis, were studied in the preneoplastic lesions, mucin-depleted foci (MDF) and aberrant crypt foci (ACF), and in colonic tumors induced in rats...
8.
Femia A, Dolara P, Giannini A, Salvadori M, Biggeri A, Caderni G
Cancer Res
. 2007 Jan;
67(2):445-9.
PMID: 17234750
Mucin-depleted foci (MDF) are microscopic dysplastic lesions induced in the colon of rodents by specific colon carcinogens. Most MDF show Wnt pathway activation, whereas only a subset shows mutations in...
9.
Cardinali C, Santini S, Di Leo A, Giannini A, Lo Scocco G
Dermatol Online J
. 2006 Apr;
12(3):15.
PMID: 16638429
A 66-year-old woman was referred a 4-month history of asthenia, weight loss, productive cough, increasing dyspnea, epigastric pain, and night sweats. A B-cell non-Hodgkin lymphoma was discovered in association with...
10.
Femia A, Bendinelli B, Giannini A, Salvadori M, Pinzani P, Dolara P, et al.
Int J Cancer
. 2005 Mar;
116(1):9-15.
PMID: 15751047
Mucin-depleted foci (MDF) are purported preneoplastic lesions that can be easily visualized in the unsectioned colon of carcinogen-treated rats stained with high-iron diamine alcian blue (HID-AB). In F344 rats treated...